Share Prices & Company Research

Stockbroking

Shire

Current Price 4690.00p Bid 4650.00p Ask 4800.00p Change 0.00%
Last Updated: 18/02/2019 11:55. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Stock Details

EPIC
SHP
ISIN
JE00B2QKY057
Shares in Issue
Market cap
£m
Sector

Analyst Views (4)

Strong Buy
 
50.00%
Buy
 
25.00%
Hold
 
25.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
0.00p
Bid Price
4650.00p
Ask Price
4800.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
4690.00p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
p
52 Week Low
p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Shire Intra-day Chart

Shire News

News in this section is provided by AJ Bell

Takeda's £46bn takeover of Shire becomes effective 08 Jan 2019 | 07:14 GSK helps inject some optimism ahead of US rates decision 19 Dec 2018 | 11:52 FTSE falls as doubt re-emerges over trade war progress 05 Dec 2018 | 16:48 Shire shareholders approve £46bn takeover by Takeda 05 Dec 2018 | 14:45 Rising sterling and renewed trade war fears dog UK stocks 05 Dec 2018 | 11:54 Concerns over Chinese growth weigh on FTSE 100 30 Nov 2018 | 16:50 Trade war concerns sink FTSE 30 Nov 2018 | 11:55 UK stocks open 0.5% lower as miners weigh 30 Nov 2018 | 09:05 Shire hereditary angioedema treatment granted marketing approval in Europe 30 Nov 2018 | 07:08 Broker Forecast - Kepler Cheuvreux issues a broker note on Shire PLC 22 Nov 2018 | 08:30 Defensive stocks help to give the FTSE a lift 19 Nov 2018 | 11:45 Shire to present data on treatment for rare disease HAE at Seattle conference 16 Nov 2018 | 08:08 Shire gets European nod for hereditary angioedema treatment 19 Oct 2018 | 13:08 FTSE climbs higher on falling pound as 'no deal' fears rise 21 Sep 2018 | 17:03 Miners underpin strong open for UK stocks 21 Sep 2018 | 09:05 Shire gets Japan regulatory nod for hereditary angioedema treatment 21 Sep 2018 | 07:19 Miners boost FTSE as investors shrug off trade war drama 18 Sep 2018 | 12:00 Shire gets European marketing nod for von Willebrand disease treatment 12 Sep 2018 | 07:06 Broker Forecast - Berenberg issues a broker note on Shire PLC 07 Sep 2018 | 08:40 Storm clouds gather as the FTSE falls 31 Aug 2018 | 11:58 Shire completes sale of oncology unit to Servier for $2.4bn 31 Aug 2018 | 07:45 FTSE heads for strong Friday finish 24 Aug 2018 | 16:41 Miners boost FTSE ahead of Bank Holiday weekend 24 Aug 2018 | 11:45 UK stocks open flat as miners rise, house builders fall 24 Aug 2018 | 08:51 Shire gets FDA approval for hereditary angioedema treatment 24 Aug 2018 | 08:38 FTSE struggles as Turkey's emergency measures fail to reassure investors 13 Aug 2018 | 16:46 FTSE declines on Turkey woes 13 Aug 2018 | 12:07 Shire partner Shionogi submits new drug application in Japan for ADHD treatment 13 Aug 2018 | 07:07 Broker Forecast - Barclays Capital issues a broker note on Shire PLC 10 Aug 2018 | 08:40 Broker Forecast - Deutsche Bank issues a broker note on Shire PLC 01 Aug 2018 | 09:10

There are no financials available for this company at present.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.